An Australian court has ruled in favor of allowing a company to patent a human gene. Concerns have been voiced that allowing a company to monopolize genes will turn the human body into a commodity, and will adversely affect healthcare. The judge argued the act of removing a specific gene from the body and isolating it made it into a product “of new manufacture” and therefore open to be patented,...